reports
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
AC ACCOR SA
ENX EURONEXT NV
EDEN EDENRED SA
WCH WACKER CHEMIE AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
NK IMERYS SA
BN DANONE SA
RNO RENAULT SA
G1A GEA GROUP AG
APAML APERAM SA
ORA ORANGE SA
EO FAURECIA SA
VAC PIERRE & VACANCES SA
HO THALES SA
GTT GAZTRANSPORT & TECHNIGAZ SA
IDL ID LOGISTICS GROUP
GBF BILFINGER SE
TFI TELEVISION FRANCAISE 1 SA
AFX CARL ZEISS MEDITEC AG
RHM RHEINMETALL AG
BLC BASTIDE LE CONFORT MEDICAL SA
TEP TELEPERFORMANCE SE
SWP SWORD GROUP SE
ITRK INTERTEK GROUP PLC
AUB AUBAY SA
VETO VETOQUINOL SA
MRN MERSEN SA
LSS LECTRA SA
JCQ JACQUET METALS SA
GLO GL EVENTS SA
RF EURAZEO SA
CDA COMPAGNIE DES ALPES SA
HOT HOCHTIEF AG
ELG ELMOS SEMICONDUCTOR SE
RAND RANDSTAD NV
ACX ACERINOX SA
EBRO EBRO FOODS SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ELE ENDESA S.A.
RWE RWE AG
HEI HEIDELBERGCEMENT AG
NEX NEXANS SA
ELIS ELIS SA
FIE FIELMANN AG
AIXA AIXTRON SE
NDA AURUBIS AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
AMS AMADEUS IT GROUP SA CLASS A
EVK EVONIK INDUSTRIES AG
EDR EDREAMS ODIGEO SA
WAF SILTRONIC AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
NVG NAVIGATOR COMPANY SA
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
IBE IBERDROLA SA
VLTSA VOLTALIA
SPIE SPIE SA
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
AD KONINKLIJKE AHOLD DELHAIZE N.V.
FTG111 FLATEXDEGIRO AG
DUE DURR AG
BFSA BEFESA SA
REY REPLY S.P.A.
TFF TFF GROUP
VOD VODAFONE GROUP PLC
VOS VOSSLOH AG
GEST GESTAMP AUTOMOCION S.A.
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
WOLF SOCIETE LDC SOCIETE ANONYME
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
RBO ROCHE BOBOIS INTERNATIONAL SAS
KBX KNORR-BREMSE AG
THEP THERMADOR HOLDING SA
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
YOU ABOUT YOU HLDG AG
ALLFG ALLFUNDS (UK) LTD
DTG DAIMLER TRUCK
WAGA WAGA ENERGY SA
SPAC 468 SPAC I SE
IOS IONOS GROUP SE
DSFIR KONINKLIJKE DSM N.V.
R3NK RENK GROUP AG
SYENS SYENSQO
PLX PLUXEE NV
PLNW PLANISWARE
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
AC ACCOR SA
ENX EURONEXT NV
EDEN EDENRED SA
WCH WACKER CHEMIE AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
NK IMERYS SA
BN DANONE SA
RNO RENAULT SA
G1A GEA GROUP AG
APAML APERAM SA
ORA ORANGE SA
EO FAURECIA SA
VAC PIERRE & VACANCES SA
HO THALES SA
GTT GAZTRANSPORT & TECHNIGAZ SA
IDL ID LOGISTICS GROUP
GBF BILFINGER SE
TFI TELEVISION FRANCAISE 1 SA
AFX CARL ZEISS MEDITEC AG
RHM RHEINMETALL AG
BLC BASTIDE LE CONFORT MEDICAL SA
TEP TELEPERFORMANCE SE
SWP SWORD GROUP SE
ITRK INTERTEK GROUP PLC
AUB AUBAY SA
VETO VETOQUINOL SA
MRN MERSEN SA
LSS LECTRA SA
JCQ JACQUET METALS SA
GLO GL EVENTS SA
RF EURAZEO SA
CDA COMPAGNIE DES ALPES SA
HOT HOCHTIEF AG
ELG ELMOS SEMICONDUCTOR SE
RAND RANDSTAD NV
ACX ACERINOX SA
EBRO EBRO FOODS SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ELE ENDESA S.A.
RWE RWE AG
HEI HEIDELBERGCEMENT AG
NEX NEXANS SA
ELIS ELIS SA
FIE FIELMANN AG
AIXA AIXTRON SE
NDA AURUBIS AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
AMS AMADEUS IT GROUP SA CLASS A
EVK EVONIK INDUSTRIES AG
EDR EDREAMS ODIGEO SA
WAF SILTRONIC AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
NVG NAVIGATOR COMPANY SA
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
IBE IBERDROLA SA
VLTSA VOLTALIA
SPIE SPIE SA
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
AD KONINKLIJKE AHOLD DELHAIZE N.V.
FTG111 FLATEXDEGIRO AG
DUE DURR AG
BFSA BEFESA SA
REY REPLY S.P.A.
TFF TFF GROUP
VOD VODAFONE GROUP PLC
VOS VOSSLOH AG
GEST GESTAMP AUTOMOCION S.A.
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
WOLF SOCIETE LDC SOCIETE ANONYME
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
RBO ROCHE BOBOIS INTERNATIONAL SAS
KBX KNORR-BREMSE AG
THEP THERMADOR HOLDING SA
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
ALLFG ALLFUNDS (UK) LTD
DTG DAIMLER TRUCK
WAGA WAGA ENERGY SA
SPAC 468 SPAC I SE
IOS IONOS GROUP SE
DSFIR KONINKLIJKE DSM N.V.
R3NK RENK GROUP AG
SYENS SYENSQO
PLX PLUXEE NV
PLNW PLANISWARE
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
AC ACCOR SA
ENX EURONEXT NV
EDEN EDENRED SA
WCH WACKER CHEMIE AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
NK IMERYS SA
BN DANONE SA
RNO RENAULT SA
G1A GEA GROUP AG
APAML APERAM SA
ORA ORANGE SA
EO FAURECIA SA
VAC PIERRE & VACANCES SA
HO THALES SA
GTT GAZTRANSPORT & TECHNIGAZ SA
IDL ID LOGISTICS GROUP
GBF BILFINGER SE
TFI TELEVISION FRANCAISE 1 SA
AFX CARL ZEISS MEDITEC AG
RHM RHEINMETALL AG
BLC BASTIDE LE CONFORT MEDICAL SA
TEP TELEPERFORMANCE SE
SWP SWORD GROUP SE
ITRK INTERTEK GROUP PLC
AUB AUBAY SA
VETO VETOQUINOL SA
MRN MERSEN SA
LSS LECTRA SA
JCQ JACQUET METALS SA
GLO GL EVENTS SA
RF EURAZEO SA
CDA COMPAGNIE DES ALPES SA
HOT HOCHTIEF AG
ELG ELMOS SEMICONDUCTOR SE
RAND RANDSTAD NV
ACX ACERINOX SA
EBRO EBRO FOODS SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ELE ENDESA S.A.
RWE RWE AG
HEI HEIDELBERGCEMENT AG
NEX NEXANS SA
ELIS ELIS SA
FIE FIELMANN AG
AIXA AIXTRON SE
NDA AURUBIS AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
AMS AMADEUS IT GROUP SA CLASS A
EVK EVONIK INDUSTRIES AG
EDR EDREAMS ODIGEO SA
WAF SILTRONIC AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
NVG NAVIGATOR COMPANY SA
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
IBE IBERDROLA SA
VLTSA VOLTALIA
SPIE SPIE SA
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
AD KONINKLIJKE AHOLD DELHAIZE N.V.
FTG111 FLATEXDEGIRO AG
DUE DURR AG
BFSA BEFESA SA
REY REPLY S.P.A.
TFF TFF GROUP
VOD VODAFONE GROUP PLC
VOS VOSSLOH AG
GEST GESTAMP AUTOMOCION S.A.
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
WOLF SOCIETE LDC SOCIETE ANONYME
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
RBO ROCHE BOBOIS INTERNATIONAL SAS
KBX KNORR-BREMSE AG
THEP THERMADOR HOLDING SA
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
ALLFG ALLFUNDS (UK) LTD
DTG DAIMLER TRUCK
WAGA WAGA ENERGY SA
SPAC 468 SPAC I SE
IOS IONOS GROUP SE
DSFIR KONINKLIJKE DSM N.V.
R3NK RENK GROUP AG
SYENS SYENSQO
PLX PLUXEE NV
PLNW PLANISWARE
- Stephane Houri
IFX INFINEON TECHNOLOGIES AG
AC ACCOR SA
ENX EURONEXT NV
EDEN EDENRED SA
WCH WACKER CHEMIE AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
NK IMERYS SA
BN DANONE SA
RNO RENAULT SA
G1A GEA GROUP AG
APAML APERAM SA
ORA ORANGE SA
EO FAURECIA SA
VAC PIERRE & VACANCES SA
HO THALES SA
GTT GAZTRANSPORT & TECHNIGAZ SA
IDL ID LOGISTICS GROUP
GBF BILFINGER SE
TFI TELEVISION FRANCAISE 1 SA
AFX CARL ZEISS MEDITEC AG
RHM RHEINMETALL AG
BLC BASTIDE LE CONFORT MEDICAL SA
TEP TELEPERFORMANCE SE
SWP SWORD GROUP SE
ITRK INTERTEK GROUP PLC
AUB AUBAY SA
VETO VETOQUINOL SA
MRN MERSEN SA
LSS LECTRA SA
JCQ JACQUET METALS SA
GLO GL EVENTS SA
RF EURAZEO SA
CDA COMPAGNIE DES ALPES SA
HOT HOCHTIEF AG
ELG ELMOS SEMICONDUCTOR SE
RAND RANDSTAD NV
ACX ACERINOX SA
EBRO EBRO FOODS SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ELE ENDESA S.A.
RWE RWE AG
HEI HEIDELBERGCEMENT AG
NEX NEXANS SA
ELIS ELIS SA
FIE FIELMANN AG
AIXA AIXTRON SE
NDA AURUBIS AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
AMS AMADEUS IT GROUP SA CLASS A
EVK EVONIK INDUSTRIES AG
EDR EDREAMS ODIGEO SA
WAF SILTRONIC AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
NVG NAVIGATOR COMPANY SA
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
IBE IBERDROLA SA
VLTSA VOLTALIA
SPIE SPIE SA
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
AD KONINKLIJKE AHOLD DELHAIZE N.V.
FTG111 FLATEXDEGIRO AG
DUE DURR AG
BFSA BEFESA SA
REY REPLY S.P.A.
TFF TFF GROUP
VOD VODAFONE GROUP PLC
VOS VOSSLOH AG
GEST GESTAMP AUTOMOCION S.A.
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
WOLF SOCIETE LDC SOCIETE ANONYME
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
RBO ROCHE BOBOIS INTERNATIONAL SAS
KBX KNORR-BREMSE AG
THEP THERMADOR HOLDING SA
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
YOU ABOUT YOU HLDG AG
ALLFG ALLFUNDS (UK) LTD
DTG DAIMLER TRUCK
WAGA WAGA ENERGY SA
SPAC 468 SPAC I SE
IOS IONOS GROUP SE
DSFIR KONINKLIJKE DSM N.V.
R3NK RENK GROUP AG
SYENS SYENSQO
PLX PLUXEE NV
PLNW PLANISWARE
- Stephane Houri
ODDO : 28th ODDO BHF Forum – Feedback Day 1
We are hosting our 28th ODDO BHF Forum in Lyon on 9 and 10 January 2025. In total, 211 companies will be presenting over the two days. In the following note, we provide some initial feedback from the companies on day 1. Out of the 104 feedbacks collected during the first day, 40 were clearly positive, 59 rather Neutral, and only 6 negative. Among the positive names, we would particularly highlight Accor, URW, Euronext, Bureau Veritas, Renke, ID Logistics, Roche Bobois, Ionos, Companie des Alpes...
IFX INFINEON TECHNOLOGIES AG
AC ACCOR SA
ENX EURONEXT NV
EDEN EDENRED SA
WCH WACKER CHEMIE AG
MT ARCELORMITTAL SA
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
NK IMERYS SA
BN DANONE SA
RNO RENAULT SA
G1A GEA GROUP AG
APAML APERAM SA
ORA ORANGE SA
EO FAURECIA SA
VAC PIERRE & VACANCES SA
HO THALES SA
GTT GAZTRANSPORT & TECHNIGAZ SA
IDL ID LOGISTICS GROUP
GBF BILFINGER SE
TFI TELEVISION FRANCAISE 1 SA
AFX CARL ZEISS MEDITEC AG
RHM RHEINMETALL AG
BLC BASTIDE LE CONFORT MEDICAL SA
TEP TELEPERFORMANCE SE
SWP SWORD GROUP SE
ITRK INTERTEK GROUP PLC
AUB AUBAY SA
VETO VETOQUINOL SA
MRN MERSEN SA
LSS LECTRA SA
JCQ JACQUET METALS SA
GLO GL EVENTS SA
RF EURAZEO SA
CDA COMPAGNIE DES ALPES SA
HOT HOCHTIEF AG
ELG ELMOS SEMICONDUCTOR SE
RAND RANDSTAD NV
ACX ACERINOX SA
EBRO EBRO FOODS SA
TRI TRIGANO SA
A1XA4J CARBIOS SA
ELE ENDESA S.A.
RWE RWE AG
HEI HEIDELBERGCEMENT AG
NEX NEXANS SA
ELIS ELIS SA
FIE FIELMANN AG
AIXA AIXTRON SE
NDA AURUBIS AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
SESL SES-IMAGOTAG SA
CIE CIE AUTOMOTIVE S.A.
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
AMS AMADEUS IT GROUP SA CLASS A
EVK EVONIK INDUSTRIES AG
EDR EDREAMS ODIGEO SA
WAF SILTRONIC AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
NVG NAVIGATOR COMPANY SA
REC RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
IBE IBERDROLA SA
VLTSA VOLTALIA
SPIE SPIE SA
MEL MELIA HOTELS INTERNATIONAL S.A.
IDR INDRA SISTEMAS S.A. CLASS A
AD KONINKLIJKE AHOLD DELHAIZE N.V.
FTG111 FLATEXDEGIRO AG
DUE DURR AG
BFSA BEFESA SA
REY REPLY S.P.A.
TFF TFF GROUP
VOD VODAFONE GROUP PLC
VOS VOSSLOH AG
GEST GESTAMP AUTOMOCION S.A.
CAF CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
WOLF SOCIETE LDC SOCIETE ANONYME
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
RBO ROCHE BOBOIS INTERNATIONAL SAS
KBX KNORR-BREMSE AG
THEP THERMADOR HOLDING SA
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
ALLFG ALLFUNDS (UK) LTD
DTG DAIMLER TRUCK
WAGA WAGA ENERGY SA
SPAC 468 SPAC I SE
IOS IONOS GROUP SE
DSFIR KONINKLIJKE DSM N.V.
R3NK RENK GROUP AG
SYENS SYENSQO
PLX PLUXEE NV
PLNW PLANISWARE
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Thomas Vranken
- Wim Lewi
- Jacob Mekhael
MaaT Pharma MaaT013 phase 3 beats expectations in aGvHD, MAA submissio...
MaaT announced that the phase 3 trial of MaaT013 met its primary endpoint in 3L aGvHD with a day 28 GI-ORR of 62%, exceeding our expectations and coming in in-line with our blue-sky scenario being significantly above what was observed in the phase 2 trial, and more or less in line with results from the early access program (EAP). Additionally, the company unexpectedly reported survival data showing a survival probability of 54%, higher than the 15% observed in the literature for off-label option...
MaaT Pharma Announces Positive Topline Results from the Pivotal Phase ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today announced topline results from ARES, a pivotal, single-arm, open-label, multicenter European Phase 3 study evaluating the efficacy and safety of MaaT013 in acute Graft-versus-Host Disease patients with gastrointestinal involvement (GI-aGvHD) in third-line treatment, meaning refractory to steroids and refractor...
MaaT Pharma annonce des résultats positifs pour l'étude pivotale de Ph...
LYON, France--(BUSINESS WIRE)-- Regulatory News : (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce aujourd'hui les résultats principaux d’ARES, une étude européenne pivotale de Phase 3 multicentrique, ouverte et à un seul bras, évaluant l'efficacité et la sécurité de MaaT013 chez des patients atteints de la maladie aiguë du greffon contre l'hôte avec atteinte gastro-...
GROUPE GUILLIN : BILAN SEMESTRIEL DE LIQUIDITE
GROUPE GUILLIN : BILAN SEMESTRIEL DE LIQUIDITE Bilan SEMESTRIEL S2 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont Au titre du contrat de liquidité confié par la société GROUPE GUILLIN à la Société de Bourse Gilbert Dupont, à la date du 31 décembre 2024, les moyens suivants figuraient au compte de liquidité : Nombre d’actions : 7 122Solde en espèces : 209 437,36 € Au cours du 2ème semestre 2024, il a été négocié un total de : ACHAT30 076 titres852 338,65 €1 530 transactionsVENTE32 078 titres 907 517,65 €1 165 transactions Il est rappelé que lors du bilan sem...
MaaT Pharma : Information mensuelle relative au nombre total de droits...
LYON, France--(BUSINESS WIRE)-- Regulatory News : (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, publie le nombre d'actions composant son capital et le nombre total de droits de vote (articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF) au 31 décembre 2024. Place de cotation : Euronext Paris Code ISIN : FR0012634822 Site web : Date ...
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Wim Lewi
- Jacob Mekhael
MaaT Pharma We're confident going into MaaT013's phase 3 topline in aG...
With recruitment completed for the phase 3 trial of lead program MaaT013 in aGvHD, topline data with GI-ORR is pinned for January 2025. We preview the upcoming readout and expect 15-20% upside if our base case materialises. We update our model to increase our peak sales expectations for MaaT013 in aGvHD to € 170m (from € 100m), which ups our TP to € 16 (from € 14). While this initial program represents a smaller commercial opportunity for MaaT, we see the results for MaaT013 as key to validate t...
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Wim Lewi
- Jacob Mekhael
MaaT Pharma MaaT013 EAP data shows continued benefit, phase 3 topline ...
MaaT presented updated results from the early access program (EAP) for lead candidate MaaT013 (microbiome therapy, enema formulation) in aGvHD in Europe during the American Society of Hematology (ASH) conference. We continue to be encouraged by the strong responses observed in the subset of 58 patients resembling the population enrolled in the phase 3 (ARES) trial, which in our view provides comfort ahead of the upcoming topline readout in January 2025. We reiterate our € 14 TP and BUY rating.
CORRIGE ET REMPLACE : MaaT Pharma présente des données actualisées pos...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Ce communiqué remplace celui publié le 9 décembre 2024 à 18h00 pour la raison suivante: Mise à jour du sous-titre. MaaT Pharma présente des données actualisées positives pour MaaT013 issues du programme d’accès compassionnel au Congrès Annuel 2024 de l’ASH MaaT Pharma organise un webinaire avec des experts le 17 décembre 2024 pour détailler les données et échanger sur les besoins médicaux non satisfaits dans la maladie aiguë du greffon contre l’hôte (aGvH) – Inscription . Taux de réponse durable à 28 jours : le taux de réponse globale g...
CORRECTING and REPLACING: MaaT Pharma Presented Positive Updated Data ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: This replaces the announcement made at 18:00 CET on 9 December 2024 due to the following corrections: Updated subheadline. MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting MaaT Pharma to host a KOL webinar on December 17th, 2024, to discuss data and the unmet medical need in acute Graft-versus-Host Disease (aGvHD) - Register . Sustained High Response Rates at Day 28: Gastrointestinal Overall Response Rate (GI-ORR) was 51% and Overall Response Rate (ORR) for all organs was 49%....
MaaT Pharma présente des données actualisées positives pour MaaT013 is...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET) visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, a annoncé aujourd’hui que le Professeur Florent Malard, professeur d’hématologie à l’hôpital Saint-Antoine (AP-HP) et à Sorbonne Université a détaillé les données actualisées portant sur 154 patients atteints de la maladie aiguë du greffon contre l’hôte (aGvH) traités avec MaaT01...
MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Ac...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announced that Prof. Malard, MD, hematology professor at Saint-Antoine Hospital and Sorbonne University, today detailed updated data for 154 patients with acute Graft-versus-Host Disease (aGvHD) treated with MaaT013 in Early Access Program (EAP) in Europe during the 66th American Society of Hematology (ASH) Annual M...
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.